You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

376 Results
Document
Sep 2019
Document
Oct 2019
Guidelines and Advice
Status: Current
ID: GL 17-12
Version: N/A
Sep 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Guidelines and Advice
Status: Current
ID: 7-A-2018-2
Version: N/A
Jan 2020
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
iBRUtinib (Unfunded),
riTUXimab (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2020

Pages